» Authors » Michael A Valente

Michael A Valente

Explore the profile of Michael A Valente including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 54
Citations 178
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Giri B, Holubar S, Liska D, Lavryk O, Cohen B, Valente M, et al.
Dis Colon Rectum . 2025 Jan; 68(2):227-233. PMID: 39847800
Background: Patients with Crohn's disease face an elevated risk of colorectal cancer, in part due to underlying chronic inflammation. Biologic therapy is the mainstay of medical treatment; however, the impact...
2.
Lavryk O, Maspero M, Holubar S, Kanters A, Liska D, Valente M, et al.
J Gastrointest Surg . 2025 Jan; 29(4):101938. PMID: 39842768
Background: This study aimed to report the experience over 40 years and outcomes of 5070 patients who underwent a pelvic pouch procedure. Methods: A retrospective analysis of a prospectively maintained...
3.
Sobrado L, Schabl L, Foley N, Prien C, Nahas S, Liska D, et al.
Dis Colon Rectum . 2025 Jan; 68(4):466-474. PMID: 39787400
Background: Deloyers technique addresses challenges in restoring bowel continuity after extended left hemicolectomies. Despite being first described in 1958, the technique remains underused, with limited data on long-term outcomes. Objective:...
4.
Erozkan K, Liska D, Oktem A, Alipouriani A, Schabl L, Valente M, et al.
Am J Surg . 2024 Nov; 241:116104. PMID: 39577038
Background: We aim to compare the relative performance of flexible sigmoidoscopy (FS), rectal magnetic resonance imaging (MRI), and their combinations during interim (i) and final (f) analysis to evaluate concordance...
5.
Chapman Jr W, Gorgun E, Yilmaz S, Rosen D, Valente M, Valente M, et al.
Dis Colon Rectum . 2024 Nov; 68(2):190-198. PMID: 39527827
Background: Among patients with rectal cancer treated with total neoadjuvant therapy, it is unclear whether early, postinduction restaging is associated with final tumor response. If so, interim restaging may alter...
6.
Yilmaz S, Liska D, Conces M, Tursun N, Elamin D, Ozgur I, et al.
Dis Colon Rectum . 2024 Sep; 68(1):60-68. PMID: 39260428
Background: Total neoadjuvant therapy in the treatment of stage II and III rectal cancer involves the administration of either induction or consolidation chemotherapy with chemoradiation before surgery. Total neoadjuvant therapy...
7.
Alipouriani A, Elsoukkary S, Erozkan K, Sommovilla J, Bhatt A, Valente M, et al.
J Gastrointest Surg . 2024 Sep; 28(12):1963-1969. PMID: 39243809
Background: Submucosal injection of lifting agents (LAs) is frequently used to facilitate endoscopic mucosal resection or endoscopic submucosal dissection. ORISE (Boston Scientific Corporation) gel, approved in 2018 by the United...
8.
Erozkan K, Elamin D, Tasci M, Liska D, Valente M, Alipouriani A, et al.
J Gastrointest Surg . 2024 Jul; 28(10):1605-1612. PMID: 39067745
Background: There is a paradigm shift in the management of locally advanced rectal cancer (LARC) from conventional neoadjuvant treatment to total neoadjuvant therapy (TNT). Despite its growing acceptance, there are...
9.
Sobrado L, Foley N, Lincango E, Liska D, Gorgun E, Hull T, et al.
Langenbecks Arch Surg . 2024 Jun; 409(1):178. PMID: 38850452
Purpose: Limited data exist regarding the surgical outcomes of acute colonic pseudo-obstruction (ACPO), commonly referred to as Ogilvie syndrome, in modern clinical practice. The prevailing belief is that surgery should...
10.
Lincango E, Hernandez Dominguez O, Prien C, Duraes L, Jia X, Uchino T, et al.
Colorectal Dis . 2024 Apr; 26(5):886-898. PMID: 38594838
Aim: Restorative proctocolectomy with transabdominal ileal pouch-anal anastomosis (abd-IPAA) has become the standard surgical treatment for medically refractory ulcerative colitis (UC). However, it requires a technically difficult distal anorectal dissection...